Checchi Capital Advisers’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $384K | Buy |
732
+50
| +7% | +$26.3K | 0.02% | 393 |
|
|
2025
Q1 | $433K | Buy |
682
+9
| +1% | +$5.71K | 0.02% | 361 |
|
|
2024
Q4 | $479K | Sell |
673
-19
| -3% | -$13.5K | 0.03% | 330 |
|
|
2024
Q3 | $727K | Sell |
692
-1
| -0.1% | -$1.05K | 0.04% | 247 |
|
|
2024
Q2 | $728K | Buy |
693
+3
| +0.4% | +$3.15K | 0.04% | 240 |
|
|
2024
Q1 | $664K | Buy |
690
+23
| +3% | +$22.1K | 0.05% | 265 |
|
|
2023
Q4 | $586K | Buy |
667
+46
| +7% | +$40.4K | 0.05% | 276 |
|
|
2023
Q3 | $511K | Sell |
621
-36
| -5% | -$29.6K | 0.05% | 282 |
|
|
2023
Q2 | $472K | Buy |
657
+8
| +1% | +$5.75K | 0.04% | 303 |
|
|
2023
Q1 | $533K | Buy |
649
+19
| +3% | +$15.6K | 0.05% | 276 |
|
|
2022
Q4 | $455K | Sell |
630
-99
| -14% | -$71.4K | 0.05% | 295 |
|
|
2022
Q3 | $502K | Buy |
729
+12
| +2% | +$8.26K | 0.05% | 264 |
|
|
2022
Q2 | $417K | Buy |
717
+118
| +20% | +$68.6K | 0.04% | 324 |
|
|
2022
Q1 | $418K | Buy |
599
+69
| +13% | +$48.2K | 0.04% | 310 |
|
|
2021
Q4 | $335K | Buy |
530
+4
| +0.8% | +$2.53K | 0.03% | 360 |
|
|
2021
Q3 | $318K | Buy |
526
+23
| +5% | +$13.9K | 0.03% | 345 |
|
|
2021
Q2 | $281K | Sell |
503
-85
| -14% | -$47.5K | 0.03% | 391 |
|
|
2021
Q1 | $278K | Sell |
588
-74
| -11% | -$35K | 0.03% | 386 |
|
|
2020
Q4 | $320K | Sell |
662
-49
| -7% | -$23.7K | 0.03% | 313 |
|
|
2020
Q3 | $398K | Buy |
711
+5
| +0.7% | +$2.8K | 0.04% | 236 |
|
|
2020
Q2 | $440K | Buy |
706
+79
| +13% | +$49.2K | 0.05% | 214 |
|
|
2020
Q1 | $306K | Sell |
627
-25
| -4% | -$12.2K | 0.03% | 239 |
|
|
2019
Q4 | $245K | Buy |
+652
| New | +$245K | 0.03% | 349 |
|
|
2019
Q2 | – | Sell |
-487
| Closed | -$200K | – | 434 |
|
|
2019
Q1 | $200K | Buy |
+487
| New | +$200K | 0.02% | 384 |
|
|
2018
Q4 | – | Sell |
-689
| Closed | -$278K | – | 422 |
|
|
2018
Q3 | $278K | Buy |
689
+22
| +3% | +$8.88K | 0.03% | 327 |
|
|
2018
Q2 | $230K | Buy |
667
+38
| +6% | +$13.1K | 0.03% | 345 |
|
|
2018
Q1 | $217K | Sell |
629
-12
| -2% | -$4.14K | 0.03% | 359 |
|
|
2017
Q4 | $241K | Buy |
641
+101
| +19% | +$38K | 0.03% | 342 |
|
|
2017
Q3 | $241K | Sell |
540
-22
| -4% | -$9.82K | 0.02% | 322 |
|
|
2017
Q2 | $276K | Sell |
562
-64
| -10% | -$31.4K | 0.03% | 286 |
|
|
2017
Q1 | $243K | Buy |
626
+29
| +5% | +$11.3K | 0.03% | 325 |
|
|
2016
Q4 | $219K | Sell |
597
-42
| -7% | -$15.4K | 0.03% | 326 |
|
|
2016
Q3 | $257K | Buy |
639
+53
| +9% | +$21.3K | 0.03% | 290 |
|
|
2016
Q2 | $205K | Sell |
586
-21
| -3% | -$7.35K | 0.02% | 329 |
|
|
2016
Q1 | $219K | Sell |
607
-120
| -17% | -$43.3K | 0.05% | 306 |
|
|
2015
Q4 | $395K | Buy |
727
+193
| +36% | +$105K | 0.1% | 176 |
|
|
2015
Q3 | $248K | Buy |
534
+9
| +2% | +$4.18K | 0.07% | 257 |
|
|
2015
Q2 | $268K | Sell |
525
-26
| -5% | -$13.3K | 0.07% | 252 |
|
|
2015
Q1 | $249K | Buy |
551
+36
| +7% | +$16.3K | 0.07% | 264 |
|
|
2014
Q4 | $211K | Buy |
+515
| New | +$211K | 0.08% | 279 |
|